title: Treatment of therapy related acute promyelocytic leukemia with the combination of all trans retinoic acid and arsenic trioxide without chemotherapy: a series of three patients.
authors.forename: Pankaj
authors.initials: P
authors.lastname: Malhotra
authors.forename: Neelam
authors.initials: N
authors.lastname: Varma
authors.forename: Niraj
authors.initials: N
authors.lastname: Arora
authors.forename: Reena
authors.initials: R
authors.lastname: Das
authors.forename: Alok
authors.initials: A
authors.lastname: Nath
authors.forename: Firuza D
authors.initials: FD
authors.lastname: Patel
authors.forename: Subhash
authors.initials: S
authors.lastname: Varma
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage; D002822:Choriocarcinoma / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology; D015473:Leukemia, Promyelocytic, Acute / Q000139:chemically induced* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017599:Neuroectodermal Tumors / Q000188:drug therapy / Q000473:pathology; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology; D010087:Oxides / Q000008:administration & dosage; D011379:Prognosis; D014212:Tretinoin / Q000008:administration & dosage
chemical_list: D001152:Arsenicals; D010087:Oxides; D014212:Tretinoin; D000077237:Arsenic Trioxide